Registry for people with TIPS for high portal pressure
Part of Digestive system clinical trials.
This study is a registry, meaning it collects health information to better understand people who have a TIPS procedure for high pressure in the liver’s blood vessels. It may help doctors improve how TIPS is used and monitored over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 to 99
- Have “portal hypertension,” meaning high blood pressure in the liver’s main veins
- You are expected to get—or already have had—a TIPS procedure (a liver blood-flow shunt placed through a neck vein)
- Be able to provide informed consent (agree to take part)
- Your consent must not be withdrawn after enrolling
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is a registry study that collects information from people who need a procedure called TIPS for portal hypertension. It may help doctors better understand outcomes and care for both cirrhotic and non-cirrhotic causes of portal hypertension.
This trial looks at a follow-up and monitoring program after TIPS (a procedure to improve blood flow in the liver). It is meant to make sure the TIPS is working and to guide follow-up without relying on invasive testing when possible.
This trial tests a special stent to treat high blood pressure in the liver caused by cirrhosis. It may help patients who need a procedure called TIPS to improve blood flow.
This trial tests a new method using electromagnetic positioning to help guide ultrasound during a TIPS procedure, which creates a connection between two blood vessels in the liver to reduce pressure. It may help people with various liver-related conditions who need this procedure.
This trial compares patients who have a rare liver condition (porto-sinusoidal vascular disease) with those who have cirrhosis, to see how a procedure called TIPS (a shunt placed in the liver to reduce blood pressure) works for complications like bleeding, fluid buildup, or blood clots.
This trial tests a new type of stent placed inside the liver to lower high blood pressure in the portal vein (a major vein that carries blood to the liver). It is aimed at people with cirrhosis who have serious complications like bleeding in the esophagus or stomach, or fluid buildup in the belly that does not go away. The study will see how safe and effective this stent is.
Hear when a new Portal Hypertension trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.